Renascience Inc. (TYO:4889)
Japan · Delayed Price · Currency is JPY 2,023.00
+77.00 (3.96%)
Mar 6, 2026, 3:30 PM JST
Renascience Market Cap
Renascience has a market cap or net worth of 26.8 billion as of March 6, 2026. Its market cap has increased by 73.84% in one year.
Market Cap
26.80B
Enterprise Value
24.39B
Revenue
107.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
2,023.00
Market Cap Chart
Since September 24, 2021, Renascience's market cap has increased from 10.13B to 26.80B, an increase of 164.50%. That is a compound annual growth rate of 24.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 26.80B | 45.76% |
| Dec 30, 2025 | 18.39B | 387.08% |
| Dec 30, 2024 | 3.78B | -31.57% |
| Dec 29, 2023 | 5.52B | 18.26% |
| Dec 30, 2022 | 4.67B | -46.27% |
| Dec 30, 2021 | 8.68B | -14.33% |
| Sep 24, 2021 | 10.13B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Japan Tissue Engineering | 29.69B |
| AnGes | 22.55B |
| RaQualia Pharma | 21.75B |
| StemRIM | 18.62B |
| ReproCELL | 16.00B |
| Stella Pharma | 15.96B |
| CanBas | 15.21B |
| Kubota Pharmaceutical Holdings | 15.12B |